As of 2025-07-01, the Relative Valuation of TG Therapeutics Inc (TGTX) is 5.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.40 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -83.5%.
The range of the Relative Valuation is 3.96 - 11.78 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 47.8x | 26.3x |
| Forward P/E multiples | 24.5x - 51.2x | 31.9x |
| Fair Price | 3.96 - 11.78 | 5.83 |
| Upside | -88.8% - -66.7% | -83.5% |
| Date | P/E |
| 2025-07-01 | 143.55 |
| 2025-06-30 | 145.95 |
| 2025-06-27 | 148.91 |
| 2025-06-26 | 153.89 |
| 2025-06-25 | 151.10 |
| 2025-06-24 | 151.26 |
| 2025-06-23 | 148.26 |
| 2025-06-20 | 146.07 |
| 2025-06-18 | 142.60 |
| 2025-06-17 | 141.93 |
| 2025-06-16 | 144.49 |
| 2025-06-13 | 146.03 |
| 2025-06-12 | 151.54 |
| 2025-06-11 | 155.39 |
| 2025-06-10 | 159.90 |
| 2025-06-09 | 161.56 |
| 2025-06-06 | 162.45 |
| 2025-06-05 | 159.37 |
| 2025-06-04 | 150.18 |
| 2025-06-03 | 147.65 |
| 2025-06-02 | 144.97 |
| 2025-05-30 | 142.38 |
| 2025-05-29 | 144.81 |
| 2025-05-28 | 142.50 |
| 2025-05-27 | 142.90 |
| 2025-05-23 | 140.19 |
| 2025-05-22 | 138.85 |
| 2025-05-21 | 138.69 |
| 2025-05-20 | 143.84 |
| 2025-05-19 | 141.85 |
| 2025-05-16 | 139.34 |
| 2025-05-15 | 136.21 |
| 2025-05-14 | 135.44 |
| 2025-05-13 | 135.32 |
| 2025-05-12 | 141.89 |
| 2025-05-09 | 136.42 |
| 2025-05-08 | 137.31 |
| 2025-05-07 | 141.32 |
| 2025-05-06 | 141.36 |
| 2025-05-05 | 152.80 |
| 2025-05-02 | 176.16 |
| 2025-05-01 | 183.98 |
| 2025-04-30 | 184.55 |
| 2025-04-29 | 177.86 |
| 2025-04-28 | 170.44 |
| 2025-04-25 | 167.60 |
| 2025-04-24 | 163.42 |
| 2025-04-23 | 160.14 |
| 2025-04-22 | 154.06 |
| 2025-04-21 | 149.92 |